
SGLT2 inhibitors may offer benefits beyond diabetes, argues Dr. Lawenda
A physician explains why he takes an SGLT2 inhibitor off-label: the drugs cause daily urinary glucose loss and may reduce risks of heart disease, cancer and dementia and even extend lifespan. Most evidence comes from people with diabetes, and Louis frames the class as possibly slowing aging itself.
